Peptide library / MK-677

MK-677

Ibutamoren is an orally active small-molecule ghrelin-receptor agonist and growth-hormone secretagogue; it is not a peptide.

Peptide & blend guide

The short version

Why people discuss it
Discussed for sleep, appetite stimulation and muscle/body-composition goals; increased appetite can conflict with weight-loss goals. Community interest does not establish benefit or a suitable treatment.
What it is
Ibutamoren is an orally active small-molecule ghrelin-receptor agonist and growth-hormone secretagogue; it is not a peptide.
Biggest caution
Endocrine biomarker changes do not establish better sleep, muscle gain or fat loss. Long-term benefit, metabolic safety and the identity of products sold for community use remain unresolved.
Stack context
Related profiles reflect adjacent community topics or biological context. They do not establish combination benefit, compatibility or a validated regimen.

Dose and frequency reference

Reference only — not a recommendation. Amounts describe source-specific community examples, selected study regimens or the named product label. They do not establish safety, effectiveness, product identity, or a suitable dose for any person. Never convert mg, mcg, or IU into syringe “units” without the exact product concentration.

Legacy community reference: no complete dosing regimen was independently corroborated by the two new source collections.

Oral

Community reference · Not clinical guidance
Amount
10–25 mg
Frequency
Once daily
Duration / phase
8–16 weeks before reassessment

Community pattern; ibutamoren is not an approved therapy The new inbox sources do not independently corroborate this complete regimen. Reference only; this does not establish safety, effectiveness or individual suitability.

Reference source · reviewed 2026-09-12
Evidence & sources · Community source profile

AxonRep synthesizes community discussion signals from its internal research corpus. Individual creator sources remain attributed to the synthesis; public reference sites used in the latest comparison are linked separately. The synthesis is not clinical evidence.

Back to the peptide library